Financhill
Back

Intellia Therapeutics Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
14

NTLA
Intellia Therapeutics

Last Price:
$9.50
Seasonality Move:
-6.53%
Sell
35

ASND
Ascendis Pharma AS

Last Price:
$128.13
Seasonality Move:
6.98%
Sell
14
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $9.50. The Score for NTLA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $9.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $128.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 27.37 Sell
Chaikin Money Flow: -78316 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.51 - 13.09) Sell
Bollinger Bands (100): (12.69 - 20.51) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 41.37 Sell
Chaikin Money Flow: -281370 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.04 - 139.32) Sell
Bollinger Bands (100): (124.47 - 141.31) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.39 Sell
20-day SMA: 11.39 Sell
50-day SMA: 13.42 Sell
200-day SMA: 20.23 Sell
8-day EMA: 10.23 Sell
20-day EMA: 11.34 Sell
50-day EMA: 13.33 Sell
200-day EMA: 19.74 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.64 Sell
20-day SMA: 136.01 Sell
50-day SMA: 132.35 Sell
200-day SMA: 134.15 Sell
8-day EMA: 132.62 Sell
20-day EMA: 134.21 Sell
50-day EMA: 133.61 Sell
200-day EMA: 131.63 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.41 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.31 per share, and an increase next year of $5.63 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):